Graphium Biosciences, Inc. announced that it has received $4 million in a round of funding on December 7, 2023. The transaction includes the participation from new investor, Range Impact, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 USD | -7.89% | +2.64% | +29.63% |
Mar. 29 | Range Impact, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Mar. 29 | Range Impact, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+29.63% | 35.36M | |
+17.31% | 84.27B | |
+16.38% | 60.45B | |
+14.42% | 23.23B | |
+11.17% | 10.46B | |
+15.32% | 10.29B | |
-13.32% | 5.87B | |
+12.26% | 4.42B | |
+14.10% | 4.42B | |
-8.55% | 2.9B |
- Stock Market
- Equities
- RNGE Stock
- News Range Impact, Inc.
- Graphium Biosciences, Inc. announced that it expects to receive $4 million in funding from Range Impact, Inc.